Item – Theses Canada

​
OCLC number
1032928024
Link(s) to full text
LAC copy
LAC copy
Author
Ismail, Ethar.
Title
Generic Drug Pricing and Substitution in Private Drug Plans in Canada.
Degree
MAST -- University of Toronto, 2014
Publisher
Toronto : University of Toronto, 2014.
Description
1 online resource
Notes
Includes bibliographical references.
Abstract
Purpose: To estimate the willingness and ability of private plans to manage costs during the generic drug procurement reform era that began in 2006 in Canada. Two cost management aspects were assessed; the prices paid for generic drugs and the extent to which private plans have enacted measures to increase generic substitution. Methods: IMS-Brogan Pharmastat data was used to estimate the price of commonly prescribed generic drugs and generic share of prescriptions, by plan type, province and quarter from 2003 to 2012. Results: Prices did not decline unless the provincial governments mandated the reductions. Savings from this mandate was approximately $264 million in Ontario. Rates of generic substitution were unaffected by the price reductions, possibly because the rates were high beforehand. Conclusion: Private plans did not independently obtain lower generic prices. Due to already high substitution rates, there may have been limited potential for additional savings from mandatory substitution controls.
Other link(s)
hdl.handle.net
tspace.library.utoronto.ca
Subject
Private insurance.
Generic drug.
Drug reimbursement.
Drug substitution.
Drug costs.
0572.
0501.